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Abstract
Most commonly used for the treatment of Parkinson’s disease (PD), the deep 
brain stimulation (DBS) is a new neurosurgical method whose other applications 
are still under development. Neuroimaging has a variety of main roles in DBS 
including evaluating the final electrode contact position, localizing the target 
nucleus, and detecting complications. Despite being a neurosurgical method, 
successful DBS intervention is highly dependent on an appropriate neuroimag-
ing technique. For achieving satisfying clinical results, DBS needs the presence 
of neuroradiologists. In this chapter, we have reviewed the role of neuroimaging 
in all stages of deep brain stimulation as well as the underlying mechanism in this 
domain.
Keywords: neuroimaging, neurostimulation, deep brain stimulation, functional 
neurosurgery
1. Introduction
Most commonly used for the treatment of Parkinson’s disease (PD), the deep 
brain stimulation (DBS) is a new neurosurgical method which its other applica-
tions is still under development [1]. Neuroimaging has a variety of main roles in 
DBS including evaluating the final electrode contact position, localizing the target 
nucleus, and detecting complications.
Benabid et al. were the very first researchers who introduced the chronic high-
frequency stimulation of the ventral intermediate nucleus (VIM) of the thalamus 
in early 1990s [2]. The authors used a subcutaneous pulse generator, which was 
implanted in the thoracic region, connected to chronic stimulating electrodes in 
the VIM for treatment of 6 patients with essential tremor and 26 patients with 
Parkinson’s disease (PD). The patients maintained improvement up to 29 months. 
As the first clinical effort to introduce the chronic high-frequency stimulation of 
nuclei (deep brain stimulation), this study showed that this newly come up method 
could be used instead of common destructive surgeries such as thalamotomy.
Another similar technique, bilateral DBS of the subthalamic nucleus (STN), was 
then introduced by the Benabid team for the treatment of severe motor fluctua-
tions and akinetic rigid Parkinson’s disease [3]. In 2002, the USA food and drug 
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administration (FDA) approved the treatment of Parkinson’s disease by stimulation 
of bilateral STN and the stimulation of internal globus pallidus (GPi) was approved 
in 2003. Although advanced Parkinson’s disease is the main indication for DBS, a 
number of different additional uses have been mentioned for DBS, such as Tourette 
syndrome, cluster headache, and dystonia as well as psychiatric indications such as 
major depression (MDD) and obsessive-compulsion disorders (OCDs).
Despite being a neurosurgical method, successful DBS intervention is highly 
dependent on an appropriate neuroimaging technique. For achieving satisfying 
clinical results, DBS needs the presence of neuroradiologists. In this chapter, we 
have reviewed the role of neuroimaging in all stages of deep brain stimulation.
2. Targets for DBS
A variety of indications and targets have been proposed for DBS since its 
starting era. Essential tremor and Parkinson’s disease are among the most common 
and ancient indications of DBS, which are managed by stimulation of VIM nucleus 
[4–6]. On the other hand, STN and GPi are the most effective targets for Parkinson’s 
disease DBS. It has also been reported that VIM DBS may relieve orthostatic tremor 
[6]. Tourette syndrome is another indication for DBS that is done through bilateral 
thalamic stimulation [7, 8].
Subthalamic nucleus (STN) stimulation by bilateral implantation of electrodes 
comprises a majority of DBS interventions for management of advanced Parkinson’s 
disease [9, 10]. Intractable epilepsy is another described indication for STN DBS 
[11]. Recently, different psychologic disorders, such as OCD, have been discussed 
as possible indications for STN DBS [12]. Internal globus pallidus (GPi) is another 
target for DBS, which is more commonly indicated for managing dystonia and 
advanced Parkinson’s disease [13–16]. Also, winter’s cramp and Tourette syndrome 
have been managed by DBS of GPi [17–19]. Previous studies have shown that GPi 
DBS improves Yale Global Tic Severity Scale and reduces Tic in a range of 65–96%. 
An older reported indication for DBS is chronic pain for which a variety of targets 
have been proposed from internal capsule and periventricular gray matter to 
sensory thalamus [20, 21].
A variety of other targets have been come up for DBS in management of 
psychiatric disorders such as major depression or OCD [22–25]. On the other 
hand, cluster headache has been treated by hypothalamic DBS [26]. Also, seizures 
that are resistant to medical treatment have been managed by DBS of cerebellum, 
centromedian, or anterior nucleus of thalamus and hippocampus [26–28].
3. Pre-interventional imaging
Magnetic resonance imaging (MRI) is the most commonly used modality for 
pre-interventional brain assessment in Parkinson’s disease patients who are candi-
dates for DBS, whether STN DBS or bilateral GPi. Multiple lacunae, severe atrophy, 
or leukoencephalopathy are among the MRI abnormalities that contraindicate DBS 
surgery [29, 30]. Some features in MRI imaging are predictors of desired or non-
appropriate postoperative results. For example, a normalized surface measure of 
mesencephalon is correlated with satisfying clinical effects of bilateral STN stimu-
lation on motor disability in Parkinson’s disease; while, a smaller surface of mesen-
cephalon is more associated with non-desired results of stimulation [31]. Also, it 
has been mentioned that brain atrophy is not related to non-desired postoperative 
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clinical results in patients who are candidates for bilateral STN stimulation. There 
is a supporting hypothesis for connecting these imaging features to post-interven-
tional clinical results that believes that a small mesencephalic surface area is cor-
related with cognitive impairment and non-dopaminergic non-levodopa responsive 
axial motor symptoms that do not appropriately respond to STN stimulation.
Imaging modalities have an important role in targeting for DBS. Appropriate 
placement of electrodes is a sensitive and difficult neurosurgical technique, which 
involves highly skilled surgeons. In the first stage of DBS, anatomical landmarks are 
determined by MR imaging. Previously, invasive ventriculography was used to deter-
mine the anatomical landmarks for STN implantation; however, it is very uncommon 
these days [32]. MR imaging has two remarkable benefits: first of, it can be easily used 
for stereotactic targeting in DBS surgery and second, electrodes can be accurately 
implanted with no additional negative effects [33, 34]. Another option for targeting is 
MR imaging/CT fusion technique in which the data acquired from the two modalities 
are fused and MR imaging with stereotactic condition is not used anymore [35].
4. Imaging during intervention
Plain control radiographs are more commonly used by most of the neurosurgery 
teams during placement of implants to ensure that the electrodes are accurately 
following the predetermined pathway [36]. In addition, intraoperative use of MR 
imaging or CT scan has been recently developed for this purpose [37, 38].
Although it has remained a controversy, electrophysiological study of brain has 
been used intraoperatively for checking electrode placement in DBS surgery. Some 
neurosurgeons consider electrophysiologic mapping of the anatomic target during 
STN electrode implantation while others prefer not to apply it, as it prolongs the 
surgery and may be associated with risks and complications [39–41].
5. Postoperative imaging
In most of the cases, postoperative imaging is performed to detect the possible 
complications. CT scan is the most common modality that is used for this purpose. 
It seems that MR imaging has a higher sensitivity in comparison with CT scan for 
some complications; for example, electrode-related infections are more detected 
by MR imaging. Also, MR imaging correctly indicates the position of contact of 
implanted electrodes. MR imaging study provides a bunch of valuable data includ-
ing the exact position of electrodes in case of clinical failure and also relationships 
between electrode and the target. Neurosurgeons more commonly register an atlas 
on postoperative MR imaging for checking the exact position of contact. Electrode 
heating is the most common complication of MR imaging, which is induced by 
electromagnetic waves [42, 43].
Post-interventional imaging has provided a remarkable source of data for 
discovering new therapeutic methods for many neurologic and psychiatric diseases. 
When undesired symptoms and manifestations are presented after DBS, research-
ers can assess the effect by imaging and this will lead to identification of new targets 
for managing a variety of disorders. It was found that bilateral hypothalamic DBS, 
which was used for treating morbid obesity, has evoked detailed autobiographic 
memories [44]. Also, the correlation of severe obsession and hyperactivity of cau-
date nucleus was found during intraoperative electrophysiologic study of caudate 
nucleus DBS in patients with OCD [45].
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6. PET, fMRI, and DBS
Functional MRI (fMRI) is a neuroimaging modality with a wide range of appli-
cation in both biomedical research and clinical studies. In addition to its high reso-
lution for soft tissue imaging, MRI has the ability to assess physiological parameters 
including metabolites, diffusion, or hemodynamics [46]. Neuronal activity causes 
a secondary hemodynamic response, including a local vascular response, which 
can be measured by fMRI [47, 48]. fMRI has promoted our understanding about 
behavioral and translational neuroscience as it has provided human brain function 
maps in addition to conventional anatomical imaging.
When it comes to DBS, positron emission tomography (PET) scan is more pre-
ferred than fMRI as it provides a safer modality for studying patients during DBS 
intervention. PET is used for studying both mechanism and unexpected effects of 
DBS [49]. According to these facilities, PET has become a gold standard for imaging 
of in vivo neurochemistry.
Combination of fMRI and PET modalities has provided a terrific opportunity 
in research to understand the neurochemistry of brain and underlying biochemical 
nature of brain function.
7. Diffusion tensor imaging (DTI)
Diffusion tensor imaging is an emerging modality that enables us to characterize 
microstructure of white matter and this may help with further development of tar-
geting methods and brain stimulation therapies [50]. The technology used behind 
the DTI is measuring three-dimensional movement of water molecules in biological 
tissue. DTI calculates diffusion of water in three dimensions by fitting a tensor to 
each voxel of a brain diffusion-weighted MR scan [51]. Three-dimensional visual-
ization of brain white matter pathways can be provided by DTI-based tractography 
[52, 53]. This has resulted in better understanding of brain anatomical structure, 
which can be implied in neurosurgical procedures [54, 55].
Defining accurate position of targets is a key point in neurosurgical stimulation 
process. The role of DTI in detailed visualization of white matter becomes more 
important when the conventional imaging modalities cannot reliably show the 
putative target location [50]. Tractography-guided neuromodulation has been tried 
for DBS in patients with Parkinson’s disease and dystonia. This will help surgeons 
with finding individual anatomic variations and so achieving better results.
8. Less invasive stimulation modalities
Neuromodulation carries a vast range of procedures from pharmacological 
interferences to the direct stimulation of brain with placed electrodes. Noninvasive 
brain stimulation (NIBS) devices work based on transferring electrical currents into 
the brain (usually cortex) through externally placed electrodes. These currents may 
be alternating or even created by magnetic fields [56]. In addition to its developed 
application in research, NIBS has dramatically entered to the clinical management 
of several neurologic/psychiatric disorders. Repeated trains of transcranial mag-
netic stimulation (rTMS) were first approved by FDA for management of major 
depressive disorders and obsessive-compulsive disorders, while migraine headaches 
are managed by single pulse TMS [56, 57].
A dynamic magnetic field is produced by TMS devices, which induces a 
consequent electric field through the skull and scalp. When this electric field is 
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delivered to the motor cortex, neurons forming the corticospinal tract are depo-
larized at the junction of gray and white matter. In addition, axons in superficial 
layers of cortex including interneurons and thalamocortical afferents can be trig-
gered by TMS pulses. TMS has effects on various brain neurotransmitter systems 
including their second messengers and receptors. Also, it promotes synaptic 
plasticity, which is a justification for TMS use in pain management. On the other 
hand, some previously published researches have indicated that TMS is effective 
in reducing frequency of epileptic attacks in patients with medically refrac-
tory epilepsy, without imposing any additional side effects. Another pilot study 
holds the belief that TMS in combination with EEG is an appropriate method for 
developing quantitative biomarkers of cortical hyperexcitability in patients with 
epilepsy [58].
A considerable problem with application of rTMS is its variable effects among 
different patients [59, 60]. This makes the research results’ replication a problem 
and application of rTMS to clinical therapeutic setting a controversial issue. When 
we use rTMS in a precise cortical area, it will equally affect all the neuronal popula-
tions and consequent behaviors involving that area [61]. Therefore, combination 
of EEG and rTMS seems to be an appropriate method in order to specify the rTMS 
effects in patients through direct measurement of cortical responses to TMS pulses 
[62]. This helps with measurement of TMS-evoked potentials (TEPs) and the 
meantime effects of TMS on the recording EEG. Various TEPs’ components are 
a reflection of activity in a precise area of cortical neurons. So, this may result in 
development of more selectively targeted forms of rTMS in non-motor areas of 
the cortex.
Transcranial direct current stimulation (tDCS) is another form of noninvasive 
brain stimulation techniques that is easily available and not extensive, while the 
exact mechanism of action has not been yet discovered [63, 64]. In this method, 
electrodes are placed on the scalp and they conduct weak prolonged (about 
10–20 min) currents to brain tissues. Indeed, neuronal excitability is modulated in 
a polarity-specific manner by tDCS [65]. The modulatory effects of tDCS are the 
main role considered for this procedure as it shifts membrane polarity resulting 
to modifying the neuronal discharge. There are two subdivisions: anodal tDCS 
increases the rate of spontaneous neuronal firing by depolarizing resting membrane 
potential, while cathodal tDCS shifts the resting membrane potential to hyperpo-
larization, which leads into decreased cortical excitability [66]. tDCS has approved 
improving effects on patients with various types of anxiety disorders such as social 
anxiety disorders, generalized anxiety disorders, and anorexia nervosa as well as 
major depression and chronic pain [67–69].
Besides the proved applications of tDCS in previous studies, the effect of sham 
tDCS has not been yet completely assessed. Some previously conducted sham-
controlled studies have reported inconsistent results with placebo response, which 
make this idea more important [70].
9. Neuroimaging and neurosurgical treatment of psychiatric disorders
Progresses in neuroimaging have resulted in developing a notable amount of 
new indications of DBS for psychiatric disorders. Discovering new functions and 
relationships for internal capsule, cingulate cortex and their networks is a result 
of modern neuroimaging techniques. In the major part of the situations, nodes of 
these networks are in the regions that are responsible for functional changes in psy-
chiatric pathology that kind of confirms the benefits of conventional capsulotomy 
and cingulotomy [71].
Neurostimulation and Neuromodulation in Contemporary Therapeutic Practice
6
These days, personalized medicine has become the most commonly mentioned 
subject in the modern medicine. All the medicine-related fields are trying to find 
ways that help with individualized treatment of the diseases, thus treating patients 
instead of diseases [72]. So, psychiatrists are following this trend and modern neu-
roimaging techniques may help them with finding proper treatment for each patient 
[73]. So far, neuroimaging was used only for checking the proper placement of 
electrodes and retrograde evaluation of interventional mechanisms; however, these 
modalities will be used for planning new treatment methods and targets for DBS 
in near future. Neuroimaging can provide lots of valuable data about connectivity 
and regional volume in each patient. Thus, it not only helps with choosing the most 
appropriate approach in psychiatric neurosurgery but also simplifies prediction of 
interventional outcomes [74–76].
Looking at the recent published studies around neuroimaging, we found out that 
developing neuroimaging techniques is leading to the age of “precision surgery.” In 
this period of time, neuroimaging will change the face and approach to electrode 
implantation and patient selection as well as selection of surgical targets throughout 
individualized neuroanatomy extracted from modern neuroimaging modalities and 
technologies [74, 77, 78].
10. Conclusion
As the researches are getting more informative, more patients are going under 
DBS intervention especially for treating Parkinson’s disease. In addition, as the 
modern technologies are developed, more new applications and targets are get-
ting introduced for DBS. So, neuroimaging has a notable role in preoperative and 
postoperative sections as well as during DBS intervention. Further researches are 
required to discover more efficient imaging modalities that will lead to discovery of 
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